A dietary intervention with conjugated linoleic acid enhances microstructural white matter reorganization in experimental stroke.

Frederike A Straeten, Jan-Kolja Strecker, Anna-Lena Börsch, Bastian Maus, Maike Hoppen, Birgit Schmeddes, Lucia Härtel, Ann-Katrin Fleck, Stephanie van Zyl, Tabea Straeten, Carolin Beuker, Mailin Koecke, Louisa Mueller-Miny, Cornelius Faber, Gerd Meyer Zu Hörste, Luisa Klotz, Jens Minnerup, Antje Schmidt-Pogoda
Author Information
  1. Frederike A Straeten: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  2. Jan-Kolja Strecker: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  3. Anna-Lena Börsch: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  4. Bastian Maus: Translational Research Imaging Center, University of Münster, Münster, Germany.
  5. Maike Hoppen: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  6. Birgit Schmeddes: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  7. Lucia Härtel: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  8. Ann-Katrin Fleck: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  9. Stephanie van Zyl: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  10. Tabea Straeten: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  11. Carolin Beuker: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  12. Mailin Koecke: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  13. Louisa Mueller-Miny: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  14. Cornelius Faber: Translational Research Imaging Center, University of Münster, Münster, Germany.
  15. Gerd Meyer Zu Hörste: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  16. Luisa Klotz: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  17. Jens Minnerup: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.
  18. Antje Schmidt-Pogoda: Department of Neurology, University Hospital Münster, University of Münster, Münster, Germany.

Abstract

Background: A dietary supplementation with conjugated linoleic acid (CLA) was shown to attenuate inflammation and increase the proportions of circulating regulatory T cells (T) and M2-type macrophages in disease models such as autoimmune encephalitis and arteriosclerosis. Since T and anti-inflammatory (M2-type) macrophages were found to enhance stroke recovery, we hypothesized that CLA-supplementation might improve stroke recovery via immune modulatory effects.
Methods: Functional assessment was performed over 90 days after induction of experimental photothrombotic stroke in wild type mice ( = 37, sham  = 10). Subsequently, immunological characterization of different immunological compartments ( = 16), magnetic resonance (MR,  = 12) imaging and immunohistochemical staining ( = 8) was performed. Additionally, we tested the effect of CLA on peripheral blood mononuclear cells from human stroke patients and healthy controls ( = 12).
Results: MR diffusion tensor imaging (DTI) demonstrated enhanced microstructural reorganization of interhemispheric white matter tracts, dependent on lesion size. Functional recovery over 90 days remained unaffected. Detailed immunological analyses across various compartments revealed no significant long-term immunological alterations due to CLA. However, analyses of human blood samples post-stroke showed reduced levels of pro-inflammatory interferon-γ (IFN-γ) and tumor necrosis factor alpha (TNF-α) release by T-lymphocytes following treatment with CLA.
Conclusion: We aimed to explore the efficacy of a dietary intervention with minimal known side effects that could be accessible to human stroke patients, regardless of the degree of disability, and without the risks associated with aggressive immunomodulatory therapies. Our main findings include improved microstructural reorganization in small infarcts and a reduced inflammatory response of human T cells .

Keywords

References

Transl Stroke Res. 2016 Dec;7(6):548-561 [PMID: 27714669]
Cell. 2020 May 14;181(4):936-953.e20 [PMID: 32386544]
Nutrients. 2019 Feb 11;11(2): [PMID: 30754681]
Magn Reson Med. 2017 Feb;77(2):603-612 [PMID: 26843524]
Stroke. 2015 Sep;46(9):2628-36 [PMID: 26243225]
BMC Bioinformatics. 2006 Mar 09;7:123 [PMID: 16526949]
Biochem Biophys Res Commun. 2003 Oct 17;310(2):562-6 [PMID: 14521947]
IEEE Trans Med Imaging. 2010 Sep;29(9):1626-35 [PMID: 20304721]
Nat Commun. 2019 Nov 22;10(1):5306 [PMID: 31757960]
PLoS One. 2024 Jun 13;19(6):e0299631 [PMID: 38870172]
Exp Neurol. 2015 Oct;272:17-25 [PMID: 25819104]
Brain. 2021 May 7;144(4):1152-1166 [PMID: 33899089]
Brain Commun. 2022 Nov 21;5(1):fcac301 [PMID: 36601620]
Gastroenterology. 2004 Sep;127(3):777-91 [PMID: 15362034]
Stroke. 2016 Jun;47(6):e98-e169 [PMID: 27145936]
J Neuroinflammation. 2022 Jun 6;19(1):131 [PMID: 35761288]
Proc Natl Acad Sci U S A. 2016 Jun 21;113(25):E3558-67 [PMID: 27274063]
Neurology. 2022 Mar 8;98(10):e1002-e1012 [PMID: 34969940]
Stroke. 2022 Feb;53(2):427-436 [PMID: 35000422]
Eur Heart J. 2018 Oct 7;39(38):3499-3507 [PMID: 30165610]
Nat Commun. 2022 Feb 17;13(1):945 [PMID: 35177618]
Trends Cardiovasc Med. 2014 Jan;24(1):45-51 [PMID: 23916809]
Br J Clin Pharmacol. 2017 Jan;83(1):46-53 [PMID: 27037767]
Stroke. 2017 Dec;48(12):3190-3195 [PMID: 29070717]
Stroke. 2022 May;53(5):1788-1801 [PMID: 35135325]
J Neuroimmune Pharmacol. 2012 Dec;7(4):1017-24 [PMID: 23054371]
J Exp Med. 2003 Sep 1;198(5):725-36 [PMID: 12939340]
Nat Med. 2009 Feb;15(2):192-9 [PMID: 19169263]
Front Immunol. 2020 Feb 26;11:294 [PMID: 32174916]
Acta Neuropathol Commun. 2020 Jun 5;8(1):81 [PMID: 32503645]
EMBO Mol Med. 2022 Sep 7;14(9):e16269 [PMID: 35971650]
Stroke. 2023 Dec;54(12):3202-3213 [PMID: 37886850]
Stroke. 2018 Jan;49(1):155-164 [PMID: 29212740]
Biochem Biophys Res Commun. 2004 Oct 15;323(2):679-84 [PMID: 15369804]
J Am Coll Nutr. 2009 Feb;28(1):43-9 [PMID: 19571159]
Nat Commun. 2023 Jan 30;14(1):489 [PMID: 36717587]
Stroke. 2021 Jul;52(7):e364-e467 [PMID: 34024117]
Nat Rev Cardiol. 2022 Aug;19(8):522-542 [PMID: 35102320]
J Affect Disord. 2019 Mar 15;247:45-56 [PMID: 30654265]
Am J Clin Nutr. 2004 Jun;79(6 Suppl):1199S-1206S [PMID: 15159257]
Clin Chim Acta. 2015 Feb 20;441:33-43 [PMID: 25512166]
PLoS One. 2013 Nov 15;8(11):e80713 [PMID: 24348913]
Nat Med. 2016 May;22(5):516-23 [PMID: 27019327]
Stroke. 2019 Oct;50(10):2875-2882 [PMID: 31412755]
Oncotarget. 2017 Jan 10;8(2):3553-3567 [PMID: 27682880]
Stroke. 2017 Apr;48(4):1061-1069 [PMID: 28292872]
Atherosclerosis. 2010 Jul;211(1):96-102 [PMID: 20223456]
Stroke. 2022 May;53(5):1460-1472 [PMID: 35380050]

Word Cloud

Similar Articles

Cited By